Pages that link to "Q28192598"

The following pages link to Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations (Q28192598):

Displaying 17 items.

• Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum? (Q24536027) (← links)
• (Q28166755) (redirect page) (← links)
• Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain (Q28168735) (← links)
• Non-Steroidal Anti-Inflammatory Drugs: An Overview of Cardiovascular Risks (Q33678007) (← links)
• Randomized controlled trials of COX-2 inhibitors: an analysis of doses used and trends over time to investigate implications for comparative safety. (Q33989306) (← links)
• Prostate cancer pain management: EAU guidelines on pain management (Q34154173) (← links)
• Understanding the NSAID related risk of vascular events (Q34546560) (← links)
• Clinical use and pharmacological properties of selective COX-2 inhibitors (Q34713083) (← links)
• Nonsteroidal anti-inflammatory drugs and heart failure (Q35091934) (← links)
• Age-related endothelial dysfunction : potential implications for pharmacotherapy (Q35128658) (← links)
• Etoricoxib for arthritis and pain management (Q35166773) (← links)
• Antinociception and the new COX inhibitors: research approaches and clinical perspectives. (Q35552842) (← links)
• Problem of the atherothrombotic potential of non-steroidal anti-inflammatory drugs (Q35636594) (← links)
• Coxibs: can this class of drugs survive? (Q41433691) (← links)
• Design, Synthesis, and Biological Activity of Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine Derivatives as Anti-Inflammatory Agents. (Q47403944) (← links)
• The effects of COX-2 selective and non-selective NSAIDs on the initiation and progression of atherosclerosis in ApoE−/− mice (Q60760196) (← links)
• Design and Synthesis of Aza-/Oxa Heterocycle-Based Conjugates as Novel Anti-Inflammatory Agents Targeting Cyclooxygenase-2 (Q90335726) (← links)